Leukemia Research
Volume 26, Issue 8 , Pages 731-738 , August 2002

Effect of vinorelbine on the growth of human myeloma cell lines in vitro

Received 19 July 2001 ,Accepted 24 November 2001.

References 

  1. Barlogie B, et al.  Plasma cell myeloma-new biological insights and advances in therapy. Blood. 1989;73:865–879
  2. Barlogie B, et al.  Effective treatment of advanced myeloma refractory to alkylating agents. N. Engl. J. Med. 1984;310:1353–1356
  3. Zervas K, et al.  Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisolone (VBMCP) and interferon-alpha with melphalan and prednisolone (MP) and interfelon-alpha in patients with good-prognosis multiple myeloma: a prospective randomized study, Greek myeloma study group. Eur. J. Haematol. 2001;66:18–23
  4. Attal M, et al.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med. 1996;335:91–97
  5. Barlogie B, et al.  Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood. 1997;89:789–793
  6. Barlogie B, et al.  Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood. 1999;93:55–65
  7. Thompson CB, et al.  Apoptosis in pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  8. Blagosklonny MV, et al.  Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 1997;7:130–135
  9. Devizzi L, et al.  Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin’s disease. Ann. Oncol. 1994;5:817–820
  10. Ferme C, et al.  The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease. Ann. Oncol. 1995;6:543–549
  11. Bonfante V, et al.  Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin’s disease. Br. J. Haematol. 1998;103:533–535
  12. Rule S, et al.  Vinorelbine in the treatment of lymphoma. Hematol. Oncol. 1998;16:101–105
  13. Gomi K, et al.  Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture. Jpn. J. Cancer. Res. 1992;83:532–539
  14. Ashizawa T, et al.  Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice. Anti-Cancer Drugs. 1993;4:577–583
  15. Toh HC, et al.  Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine. Leukemia Lymphoma. 1997;31:195–208
  16. Salmon SE, et al.  Intermittent high dose prednisone therapy for multiple myeloma. Cancer Chemother Res. 1967;51:179–187
  17. Alexanian R, et al.  High-dose glucocorticoid treatment of resistant myeloma. Ann. Intern. Med. 1986;105:8–11
  18. Chen YH, et al.  Inhibition of myeloma cell growth by dexamethasone and all trans-retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood. 1996;87:314–323
  19. Goto H, et al.  Establishment of a novel myeloma cell line KPMM2 carrying t (3; 14) (q21; q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia. 1995;9:711–718
  20. Ahmed SA, et al.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to []-thymidine incorporation assay. J. Immunol. Methods. 1994;170:211–224
  21. Hardin J, et al.  Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood. 1994;84:3063–3070
  22. Herault O, et al.  A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population. Br. J. Haematol. 1999;104:530–537
  23. Takahashi R, et al.  A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells. Leukemia Res. 2001;25:77–83
  24. Fisher RI, et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N. Engl. J. Med. 1993;328:1002–1006
  25. Johnson SA, et al.  Vinorelbine: an overview. Cancer Treat. Rev. 1996;22:127–142
  26. Tsuei SE, et al.  Disposition of synthetic glucocorticoids. Part I. Pharmacokinetics of dexamethasone in healthy adults. J. Pharmacokinet. Biopharm. 1979;7:249–264

PII: S0145-2126(01)00195-3

Leukemia Research
Volume 26, Issue 8 , Pages 731-738 , August 2002

Article Tools

* Image Usage & Resolution